Andon Health announces share repurchase reaches 2% threshold

Andon Health (SZSE:002432) announced that its share repurchase program has reached a key milestone, with the company having bought back 9,629,405 shares as of April 30, 2025. This represents 2.04% of the company's total share capital. The share repurchases were conducted through a dedicated securities account using centralized bidding, with the highest transaction price at CNY42.17 per share and the lowest at CNY36.38 per share. The total expenditure for the repurchase amounts to CNY369,962,806.12, excluding transaction fees. The company initiated the repurchase program following board approval on March 26, 2025, with funds sourced from its own capital and dedicated repurchase financing. The buyback aims to utilize a total of CNY250 million to CNY500 million, at a price not exceeding CNY50 per share. Andon Health assures investors that the repurchase activities comply with relevant regulations and the established repurchase plan.